|
Showing the most relevant articles for your search:NASDAQ:KITE Date | Time | Source | Headline | Symbol | Company | 10/13/2017 | 5:05PM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:KITE | Kite Pharma, Inc. |
10/05/2017 | 3:44PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:KITE | Kite Pharma, Inc. |
10/03/2017 | 5:12PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:KITE | Kite Pharma, Inc. |
10/03/2017 | 5:07PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:KITE | Kite Pharma, Inc. |
10/03/2017 | 5:02PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:KITE | Kite Pharma, Inc. |
10/03/2017 | 4:57PM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:KITE | Kite Pharma, Inc. |
10/03/2017 | 4:56PM | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:KITE | Kite Pharma, Inc. |
10/03/2017 | 4:44PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KITE | Kite Pharma, Inc. |
10/03/2017 | 9:03AM | Edgar (US Regulatory) | (25-NSE) | NASDAQ:KITE | Kite Pharma, Inc. |
10/03/2017 | 8:46AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
10/03/2017 | 8:45AM | Business Wire | Gilead Sciences Completes Acquisition of Kite Pharma, Inc. | NASDAQ:KITE | Kite Pharma, Inc. |
10/03/2017 | 8:17AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
10/03/2017 | 8:00AM | Business Wire | Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc. | NASDAQ:KITE | Kite Pharma, Inc. |
09/26/2017 | 8:54AM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
09/26/2017 | 8:40AM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
09/26/2017 | 8:30AM | Business Wire | Gilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting Period | NASDAQ:KITE | Kite Pharma, Inc. |
09/25/2017 | 5:17PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
09/25/2017 | 5:13PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KITE | Kite Pharma, Inc. |
09/25/2017 | 4:31PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
09/22/2017 | 4:18PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
09/18/2017 | 5:29PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
09/15/2017 | 4:52PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
09/08/2017 | 5:30PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NASDAQ:KITE | Kite Pharma, Inc. |
09/08/2017 | 5:24PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
09/08/2017 | 1:37PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:KITE | Kite Pharma, Inc. |
09/07/2017 | 4:12PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NASDAQ:KITE | Kite Pharma, Inc. |
09/05/2017 | 4:13PM | Edgar (US Regulatory) | Statement of Ownership: Solicitation (sc 14d9) | NASDAQ:KITE | Kite Pharma, Inc. |
09/05/2017 | 4:09PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KITE | Kite Pharma, Inc. |
09/05/2017 | 12:24PM | Edgar (US Regulatory) | Tender Offer Statement by Third Party (sc To-t) | NASDAQ:KITE | Kite Pharma, Inc. |
09/01/2017 | 5:28PM | Edgar (US Regulatory) | Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c) | NASDAQ:KITE | Kite Pharma, Inc. |
|
Showing the most relevant articles for your search:NASDAQ:KITE |
|